First insights into community pharmacy based buprenorphine-naloxone dispensing in Finland
Tallennettuna:
Uosukainen, H., ET AL., First insights into community pharmacy based buprenorphine-naloxone dispensing in Finland. International Journal of Drug Policy, Vol. 24, no. 5 (2013), p. 492-497.
Ref.
194040
Sijainti:
SIIS R.1114 Archivo
Palabras clave:
Buprenorfina, Drogas ilegales, Drogodependencias, Farmacia, Opiáceos, Programas de mantenimiento, Reducción de daños, Tratamiento médico, Finlandia
Buprenorfina, Drogas ilegales, Drogodependencias, Farmacia, Opiáceos, Programas de mantenimiento, Reducción de daños, Tratamiento médico, Finlandia
Samankaltaisia teoksia: First insights into community pharmacy based buprenorphine-naloxone dispensing in Finland
- What is known about community pharmacy supply of naloxone? A scoping review
- Community pharmacy services for drug misuse: attitudes and practices of Finnish pharmacists
- Buprenorphine/Naloxone dose and pain intensity among individuals initiating treatment for opioid use disorder
- Buprenorphine implants for treatment of opioid dependence: randomized comparison to placebo and sublingual buprenorphine/naloxone
- A prospective, randomized, multicenter acceptability and safety study of direct buprenorphine/naloxone induction in heroin-dependent individuals
- ABUSE LIABILITY OF INTRAVENOUS BUPRENORPHINE/NALOXONE AND BUPRENORPHINE ALONE IN BUPRENORPHINE-MAINTAINED INTRAVENOUS HEROIN ABUSERS